Autoinmunidad e Inmunodeficiencias
CTS150
Hospital Universitario Virgen Macarena
Sevilla, EspañaHospital Universitario Virgen Macarena -ko ikertzaileekin lankidetzan egindako argitalpenak (31)
2024
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
2023
-
Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review
Medicina Clinica, Vol. 161, Núm. 2, pp. 65-77
2021
-
Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260
-
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
BMC Infectious Diseases, Vol. 21, Núm. 1
-
Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1928-1936
-
Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 9, pp. 1863-1871
2020
2019
-
Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects
Journal of Neuroimmune Pharmacology, Vol. 14, Núm. 3, pp. 413-422
2018
-
Diagnosis and empirical treatment for community-acquired pneumonia in special situations: immunocompromised HIV negative and elderly patients
Medicine (Spain), Vol. 12, Núm. 53, pp. 3168-3173
-
Diagnostic and therapeutic protocol for community-acquired pneumonia
Medicine (Spain), Vol. 12, Núm. 53, pp. 3162-3167
-
Diagnostic and therapeutic protocol for pleural infections
Medicine (Spain), Vol. 12, Núm. 54, pp. 3231-3234
-
Unsolicited consultation by infectious diseases specialist improves outcomes in patients with bloodstream infection: A prospective cohort study
Journal of Infection, Vol. 77, Núm. 6, pp. 503-508
2017
-
Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494
2016
-
Sarcoidosis: an update on current pharmacotherapy options and future directions
Expert Opinion on Pharmacotherapy, Vol. 17, Núm. 18, pp. 2431-2448
2015
-
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 9, pp. 1879-1884
2014
-
Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 33, Núm. 8, pp. 1439-1448
-
Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort
International Journal of Infectious Diseases, Vol. 26, pp. 83-87
2013
-
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis
Clinical Infectious Diseases, Vol. 56, Núm. 11, pp. 1646-1653
-
Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: A prospective cohort study
BMC Infectious Diseases, Vol. 13, Núm. 1
2012
-
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
AIDS, Vol. 26, Núm. 13, pp. 1721-1724